{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:54:04Z","timestamp":1792788844177,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"AFM-Telethon","award":["17224"],"award-info":[{"award-number":["17224"]}]},{"name":"European Research Council","award":["ERC-2010-AdG, GT-SKIN"],"award-info":[{"award-number":["ERC-2010-AdG, GT-SKIN"]}],"id":[{"id":"https:\/\/ror.org\/0472cxd90","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Agence nationale de la recherch\u00e9","award":["ANR-16-CE18-0004 and ANR-10-IAHU-01"],"award-info":[{"award-number":["ANR-16-CE18-0004 and ANR-10-IAHU-01"]}],"id":[{"id":"https:\/\/ror.org\/00rbzpz17","id-type":"ROR","asserted-by":"crossref"}]},{"name":"EU Marie Curie","award":["PRESTIGE_2015_2_0015"],"award-info":[{"award-number":["PRESTIGE_2015_2_0015"]}]},{"DOI":"10.13039\/501100007149","name":"Genopole","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007149","id-type":"DOI","asserted-by":"crossref"}]},{"name":"EU H2020","award":["666908"],"award-info":[{"award-number":["666908"]}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"crossref","award":["RR14008"],"award-info":[{"award-number":["RR14008"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"crossref","award":["RP170721"],"award-info":[{"award-number":["RP170721"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CRISPR Therapeutics","id":[{"id":"https:\/\/ror.org\/04ewmsk50","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ymthe.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T22:43:59Z","timestamp":1539729839000},"page":"137-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["Optimization of CRISPR\/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements"],"prefix":"10.1016","volume":"27","author":[{"given":"Annalisa","family":"Lattanzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasco","family":"Meneghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ramadier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Antoniani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Alibeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Porteus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Mavilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Miccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2018.10.008_bib1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","article-title":"Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned","volume":"21","author":"Morgan","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2018.10.008_bib2","doi-asserted-by":"crossref","first-page":"307ra156","DOI":"10.1126\/scitranslmed.aac5530","article-title":"Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template","volume":"7","author":"Sather","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.10.008_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2018.10.008_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.ge.06.120172.000403","article-title":"The molecular basis of hemoglobin disease","volume":"6","author":"Stamatoyannopoulos","year":"1972","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ymthe.2018.10.008_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM198407053110102","article-title":"Influence of sickle hemoglobinopathies on growth and development","volume":"311","author":"Platt","year":"1984","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2018.10.008_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010659","article-title":"Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease","volume":"8","author":"Madigan","year":"2006","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ymthe.2018.10.008_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev-biochem-060713-035418","article-title":"Genome engineering with targetable nucleases","volume":"83","author":"Carroll","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2018.10.008_bib8","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1073\/pnas.1612075113","article-title":"Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and \u03b2-thalassemia","volume":"113","author":"Ye","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.10.008_bib9","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ymthe.2017.03.024","article-title":"Gene Therapy for \u03b2-Hemoglobinopathies","volume":"25","author":"Cavazzana","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.10.008_bib10","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood-2017-10-811505","article-title":"Induction of fetal hemoglobin synthesis by CRISPR\/Cas9-mediated editing of the \u03b2-globin locus","volume":"131","author":"Antoniani","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.10.008_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.2507","article-title":"Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2018.10.008_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2018.10.008_bib13","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/nar\/gku749","article-title":"Multiplex CRISPR\/Cas9-based genome engineering from a single lentiviral vector","volume":"42","author":"Kabadi","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2018.10.008_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/gt.2016.27","article-title":"Lentivirus pre-packed with Cas9 protein for safer gene editing","volume":"23","author":"Choi","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2018.10.008_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/hum.2017.032","article-title":"Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T\u00a0Cells via CRISPR\/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection","volume":"29","author":"Yu","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.10.008_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.omtm.2017.04.002","article-title":"Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR\/Cas9-Mediated Gene Editing","volume":"5","author":"Ortinski","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2018.10.008_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/hum.2016.107","article-title":"Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles","volume":"27","author":"Yu","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.10.008_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13059-015-0859-y","article-title":"Towards a new era in medicine: therapeutic genome editing","volume":"16","author":"Porteus","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2018.10.008_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tibtech.2014.12.001","article-title":"Quantifying on- and off-target genome editing","volume":"33","author":"Hendel","year":"2015","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ymthe.2018.10.008_bib20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2018.10.008_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature15521","article-title":"BCL11A enhancer dissection by Cas9-mediated in\u00a0situ saturating mutagenesis","volume":"527","author":"Canver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2018.10.008_bib22","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood-2014-12-615948","article-title":"Correction of the sickle cell disease mutation in human hematopoietic stem\/progenitor cells","volume":"125","author":"Hoban","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.10.008_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm.4170","article-title":"A genome-editing strategy to treat \u03b2-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition","volume":"22","author":"Traxler","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2018.10.008_bib24","doi-asserted-by":"crossref","first-page":"360ra134","DOI":"10.1126\/scitranslmed.aaf9336","article-title":"Selection-free genome editing of the sickle mutation in human adult hematopoietic stem\/progenitor cells","volume":"8","author":"DeWitt","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.10.008_bib25","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.celrep.2016.09.092","article-title":"Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR\/Cas9","volume":"17","author":"Gundry","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2018.10.008_bib26","doi-asserted-by":"crossref","first-page":"21312","DOI":"10.1074\/jbc.M114.564625","article-title":"Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)\/Cas9 nuclease system in mammalian cells","volume":"289","author":"Canver","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2018.10.008_bib27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41467-017-00479-7","article-title":"Editing an \u03b1-globin enhancer in primary human hematopoietic stem cells as a treatment for \u03b2-thalassemia","volume":"8","author":"Mettananda","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2018.10.008_bib28","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood-2003-11-4069","article-title":"The Corfu deltabeta thalassemia deletion disrupts gamma-globin gene silencing and reveals post-transcriptional regulation of HbF expression","volume":"105","author":"Chakalova","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.10.008_bib29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood.V75.4.1000.1000","article-title":"A new hereditary persistence of fetal hemoglobin deletion has the breakpoint within the 3\u2032 beta-globin gene enhancer","volume":"75","author":"Camaschella","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.10.008_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas nuclease specificity using truncated guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2018.10.008_bib31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/scd.2006.15.278","article-title":"Nucleofection, an efficient nonviral method to transfer genes into human hematopoietic stem and progenitor cells","volume":"15","author":"von Levetzow","year":"2006","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ymthe.2018.10.008_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/pharmaceutics7030137","article-title":"Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity","volume":"7","author":"Uchida","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2018.10.008_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nmeth.1456","article-title":"Transient cold shock enhances zinc-finger nuclease-mediated gene disruption","volume":"7","author":"Doyon","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2018.10.008_bib34","doi-asserted-by":"crossref","first-page":"16067","DOI":"10.1038\/mtm.2016.67","article-title":"Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem\/progenitor cells","volume":"3","author":"DiGiusto","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2018.10.008_bib35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.hoc.2017.06.010","article-title":"Gene Therapy Approaches to Hemoglobinopathies","volume":"31","author":"Ferrari","year":"2017","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.ymthe.2018.10.008_bib36","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/mt.2016.148","article-title":"CRISPR\/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells","volume":"24","author":"Hoban","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.10.008_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.omtm.2016.12.009","article-title":"Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells","volume":"4","author":"Chang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2018.10.008_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cytogfr.2007.06.016","article-title":"The response of mammalian cells to double-stranded RNA","volume":"18","author":"Gantier","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ymthe.2018.10.008_bib39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2144\/04364BM02","article-title":"Increasing lentiviral vector titer using inhibitors of protein kinase R","volume":"36","author":"Pernod","year":"2004","journal-title":"Biotechniques"},{"key":"10.1016\/j.ymthe.2018.10.008_bib40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/gt.2009.129","article-title":"Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors","volume":"17","author":"Maetzig","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2018.10.008_bib41","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1093\/nar\/26.14.3433","article-title":"Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5\u2032 and 3\u2032 of the catalytic site","volume":"26","author":"Harrison","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2018.10.008_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0167-4781(99)00011-1","article-title":"The effect of template RNA structure on elongation by HIV-1 reverse transcriptase","volume":"1444","author":"Klasens","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2018.10.008_bib43","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2018.10.008_bib44","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nmeth.2030","article-title":"Targeted gene knockout by direct delivery of zinc-finger nuclease proteins","volume":"9","author":"Gaj","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2018.10.008_bib45","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.celrep.2017.08.075","article-title":"The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes","volume":"20","author":"Merienne","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2018.10.008_bib46","doi-asserted-by":"crossref","first-page":"15334","DOI":"10.1038\/ncomms15334","article-title":"Hit and go CAS9 delivered through a lentiviral based self-limiting circuit","volume":"8","author":"Petris","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2018.10.008_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2011-03-325258","article-title":"Fetal hemoglobin in sickle cell anemia","volume":"118","author":"Akinsheye","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.10.008_bib48","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood.V63.4.921.921","article-title":"Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?","volume":"63","author":"Powars","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.10.008_bib49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood-2013-09-528067","article-title":"Fetal hemoglobin in sickle cell anemia: a glass half full?","volume":"123","author":"Steinberg","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.10.008_bib50","doi-asserted-by":"crossref","first-page":"W462","DOI":"10.1093\/nar\/gkq319","article-title":"ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool","volume":"38","author":"Sander","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2018.10.008_bib51","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/mtna.2014.64","article-title":"COSMID: A Web-based Tool for Identifying and Validating CRISPR\/Cas Off-target Sites","volume":"3","author":"Cradick","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2018.10.008_bib52","doi-asserted-by":"crossref","first-page":"e00471","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells","volume":"2","author":"Jinek","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2018.10.008_bib53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2018.10.008_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.omtn.2017.02.004","article-title":"Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR\/Cas9 System","volume":"7","author":"Lattanzi","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2018.10.008_bib55","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2018.10.008_bib56","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","article-title":"Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9","volume":"15","author":"Mandal","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2018.10.008_bib57","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jmcb\/mjv016","article-title":"Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR\/Cas9","volume":"7","author":"Li","year":"2015","journal-title":"J.\u00a0Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2018.10.008_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","article-title":"Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2018.10.008_bib59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13059-015-0680-7","article-title":"A versatile reporter system for CRISPR-mediated chromosomal rearrangements","volume":"16","author":"Li","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2018.10.008_bib60","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2018.10.008_bib61","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2018.10.008_bib62","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nbt.3583","article-title":"Analyzing CRISPR genome-editing experiments with CRISPResso","volume":"34","author":"Pinello","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2018.10.008_bib63","series-title":"R: A language and environment for statistical computing","year":"2016"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618304970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618304970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:53:34Z","timestamp":1761501214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001618304970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1525001618304970"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.10.008","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of CRISPR\/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}